Status:
ENROLLING_BY_INVITATION
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma
Lead Sponsor:
University of California, Davis
Conditions:
Lung Neoplasm
Lymphoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To determine the minimum scan duration for fluorine-18 positron-emitting radioactive isotope-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) scans performed on...
Eligibility Criteria
Inclusion
- Ability to understand and willingness to sign an informed consent form.
- Ability to adhere to the study visit schedule and all protocol requirements.
- Men and women ≥18 years of age.
- Diagnosis or suspected diagnosis of lung cancer, melanoma or lymphoma.
- Patients who have been referred for a PET/CT scan.
Exclusion
- Pregnant women.
- Claustrophobia.
- Any significant medical condition that in the opinion of the investigator would prevent the subject from participating and/or adhering to study related procedures or interfere with subject safety.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04478318
Start Date
June 1 2020
End Date
June 1 2026
Last Update
January 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Davis
Sacramento, California, United States, 95817